Explore all companies

NTrans Technologies

Develops a non-viral, macropinocytosis-based delivery system for the efficient intracellular delivery of gene-editing tools, such as CRISPR RNPs.

Details

  • LSH Companies

J.H. Oortweg 19 , 2333 CH, Leiden

View company website